| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.0063 | 0.9 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | 0.24 | 5e-11 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.39 | 5e-09 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | 0.37 | 3e-08 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | 0.25 | 7e-07 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-06 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | 0.3 | 3e-06 |